Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
出版年份 2014 全文链接
标题
Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
作者
关键词
-
出版物
Frontiers in Immunology
Volume 5, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2014-06-13
DOI
10.3389/fimmu.2014.00281
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
- (2014) Maria Giulia Cangi et al. ANNALS OF THE RHEUMATIC DISEASES
- Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis
- (2014) Marco Chilosi et al. LEUKEMIA & LYMPHOMA
- Diagnosing Erdheim–Chester disease
- (2013) Giulio Cavalli et al. ANNALS OF THE RHEUMATIC DISEASES
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases
- (2013) Giulio Cavalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Detection of an NRAS mutation in Erdheim-Chester disease
- (2013) E. L. Diamond et al. BLOOD
- Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
- (2013) Audrey Courcoul et al. JOINT BONE SPINE
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
- (2013) Mabel Ryder et al. PLoS One
- Erdheim-Chester Disease
- (2013) Julien Haroche et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- TNF- in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab
- (2013) E. Ferrero et al. RHEUMATOLOGY
- The Relapsing Polychondritis Disease Activity Index: Development of a disease activity score for relapsing polychondritis
- (2012) Laurent Arnaud et al. AUTOIMMUNITY REVIEWS
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
- (2012) J. Haroche et al. BLOOD
- High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
- (2012) J. Haroche et al. BLOOD
- Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra
- (2012) Olivier Aubert et al. JOINT BONE SPINE
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab
- (2012) Lorenzo Dagna et al. JOURNAL OF CLINICAL ONCOLOGY
- Erdheim-Chester Disease Harboring the BRAF V600E Mutation
- (2012) Piers Blombery et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF Mutations in Erdheim-Chester Disease
- (2012) Jean-François Emile et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Erdheim-Chester Disease with Long-Term High-Dose Interferon-α
- (2012) Baptiste Hervier et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma
- (2011) Yasser Heakal et al. ANNALS OF PHARMACOTHERAPY
- CNS involvement and treatment with interferon- are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients
- (2011) L. Arnaud et al. BLOOD
- Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients
- (2011) L. Arnaud et al. BLOOD
- Erdheim-Chester Disease
- (2011) Emanuel Della Torre et al. CLINICAL NUCLEAR MEDICINE
- Langerhans cell histiocytosis and Erdheim–Chester disease
- (2011) Marta Wilejto et al. CURRENT OPINION IN RHEUMATOLOGY
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF as therapeutic target in melanoma
- (2010) Claudia Wellbrock et al. BIOCHEMICAL PHARMACOLOGY
- Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease
- (2010) A. Aouba et al. BLOOD
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- (2010) G. Badalian-Very et al. BLOOD
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis
- (2010) L. Dagna et al. RHEUMATOLOGY
- Targeting of the BRAF gene in papillary thyroid carcinoma (Review)
- (2009) Kakudo ONCOLOGY REPORTS
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
- (2008) Thomas Kuilman et al. CELL
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Amplification of Rare Mutations Using Locked Nucleic Acid Oligonucleotides that Competitively Inhibit Primer Binding to Wild-Type DNA
- (2007) Reid P. Oldenburg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now